Nektar Therapeutics chief R&D officer sells $48,048 in stock By Investing.com

Nektar Therapeutics chief RD officer sells 48048 in stock By

SAN FRANCISCO—Jonathan Zalevsky, Chief Research and Development Officer at Nektar Therapeutics …

www.investing.com

More posts

Biden administration withdraws proposed rule limiting transgender bans in sports By Reuters

December 21, 2024
Cloudflare CEO Matthew Prince sells shares worth $17.5 million By Investing.com

December 21, 2024
Wilhelmina International, Inc. Announces Voluntary Delisting from the Nasdaq Capital Market By Investing.com

December 21, 2024
Aris water solutions sees $969,637 stock sale by Gable S Corp By Investing.com

December 21, 2024